These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31333603)

  • 41. Evolution of multi-functional capillary electrophoresis for high-efficiency selection of aptamers.
    Zhu C; Yang G; Ghulam M; Li L; Qu F
    Biotechnol Adv; 2019 Dec; 37(8):107432. PubMed ID: 31437572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.
    Prakash JS; Rajamanickam K
    Biomedicines; 2015 Sep; 3(3):248-269. PubMed ID: 28536411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aptamers and Aptasensors as Novel Approach for Microbial Detection and Identification: An Appraisal.
    Syed MA; Jamil B
    Curr Drug Targets; 2018; 19(13):1560-1572. PubMed ID: 29303077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of aptamers against pathogenic bacteria and their diagnostics application.
    Wang L; Wang R; Wei H; Li Y
    World J Microbiol Biotechnol; 2018 Sep; 34(10):149. PubMed ID: 30220026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterization of 2'-F-RNA aptamers against whole HIV-1 subtype C envelope pseudovirus.
    London GM; Mayosi BM; Khati M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):428-33. PubMed ID: 25482445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.
    Yuan S; Zhang N; Singh K; Shuai H; Chu H; Zhou J; Chow BK; Zheng BJ
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4082-93. PubMed ID: 25918143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel insights into the role of aptamers in the fight against cancer.
    Maimaitiyiming Y; Hong F; Yang C; Naranmandura H
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza A virus-specific aptamers screened by using an integrated microfluidic system.
    Lai HC; Wang CH; Liou TM; Lee GB
    Lab Chip; 2014 Jun; 14(12):2002-13. PubMed ID: 24820138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of a new class of DNA aptamers specific binding to Singapore grouper iridovirus (SGIV) with antiviral activities.
    Li P; Yan Y; Wei S; Wei J; Gao R; Huang X; Huang Y; Jiang G; Qin Q
    Virus Res; 2014 Aug; 188():146-54. PubMed ID: 24768847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX).
    Huang CJ; Lin HI; Shiesh SC; Lee GB
    Biosens Bioelectron; 2010 Mar; 25(7):1761-6. PubMed ID: 20061133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycan-Imprinted Magnetic Nanoparticle-Based SELEX for Efficient Screening of Glycoprotein-Binding Aptamers.
    Ma Y; Li X; Li W; Liu Z
    ACS Appl Mater Interfaces; 2018 Nov; 10(47):40918-40926. PubMed ID: 30379519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
    Ji K; Lim WS; Li SF; Bhakoo K
    Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Aptamers in the Treatment of Bacterial Infections: Problems and Prospects].
    Zeninskaya NA; Kolesnikov AV; Ryabko AK; Shemyakin IG; Dyatlov IA; Kozyr AV
    Vestn Ross Akad Med Nauk; 2016; 71(5):350-8. PubMed ID: 29297663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases.
    Xu Y; Jiang X; Zhou Y; Ma M; Wang M; Ying B
    Front Bioeng Biotechnol; 2021; 9():704077. PubMed ID: 34447741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aptamers as Therapeutics.
    Nimjee SM; White RR; Becker RC; Sullenger BA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():61-79. PubMed ID: 28061688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.